Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4437_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
55 Мб
Скачать
246
M. Sakr
studies have reported diagnostic rates of up to 92% for US-guided FNA and approximately 98% for US-guided CNB for supra-clavicular LNs [378380]. Selection of FNA or CNB depends on operator experience, availability of cytologists/ pathologists, and imaging features of the lesion.
In the setting of a small target LN, necrotic target, or when the target is adjacent to sensitive structures, FNA may be preferred. However, it does not provide the cellular architecture required for accurate subtyping of lymphomas. When next-generation genomic sequencing is required, core biopsies of LNs have a high success rate of providing adequate tissue [381]. US guidance typically provides excellent visualization of both the target and the biopsy device. The needle should be visualized throughout its entire course.
Excision Biopsy
Supra-clavicular LN excision biopsy has remained a diagnostic tool for intra-thoracic and/ or metastatic disease, even with the development of more noninvasive procedures such as US-guided biopsy and scalene biopsy during mediastinoscopy [382].
An incision is made, often under local anes­thesia, over the clavicle and laterally to the SCM muscle. The clavicular part of this muscle can be divided, and the whole muscle is retracted more centrally to expose the area under the anterior scalenus muscle. This area contains fat and mul­tiple LNs, which can be easily and safely removed. Additionally, with the use of this tech­nique, the subclavian and jugular vessels can be followed in the mediastinum to extract more LNs and increase the possibility of diagnosis of intra­thoracic lesions [383].
A lack of understanding the anatomy may result in complications, which include (1) carotid and subclavian artery bleeding, (2) thoracic duct injury resulting in chylous stula, (3) phrenic or RLN injury, (4) wound infection, and (5) tumor seeding in cases of human papillomavirus­positive head and neck SCC [384, 385].
According to the latest guidelines set by the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), an open biopsy is only necessary if FNAC, CNB, physical exam-
inations, and other ancillary test prove to be non­diagnostic [384].
10.6.5.5 Dierential Diagnosis
The differential diagnosis of supra-clavicular lymphadenopathy generally categorizes as neo­plastic, infectious, inammatory, and reactive lesions. Ellison etal. (1999) performed a retro­spective 5-year study in a large hospital on 309 supra-clavicular masses diagnosed with FNA. Results showed that most of the masses (55%) were malignant, with secondary (metastatic spread) being far more frequent than primary lymphomas (47% versus 8%, respec­tively) [378].
10.6.5.6 Prognosis
Prognosis of malignant infra-diaphragmatic tumors after metastasis to Virchow’s node is gen­erally extremely poor [386]. In case of abdominal malignancy, identication of supra-clavicular lymphadenopathy is considered as distant meta­static disease, which has a 5-year survival rate of only 4%, and often precludes surgical resection [365]. In case of intra-thoracic malignancy, lung cancer has been reported to have the highest mor­tality of all cancers in the United States, and dis­ease spread to the scalene LNs (N3) may contraindicate surgical therapy [387]. In general, prognosis may depend on the characteristics of the primary tumor, and rapid diagnosis is impor­tant for providing appropriate treatment [388].
10.7 Cystic Swellings ofthePosterior Triangle
10.7.1 Cystic Hygroma
10.7.1.1 Denition
A cystic hygroma is dened as “sequestration of some lymphatics and loss of communication with the main trunk” [389]. It can arise anywhere in the body but is classically found in the posterior triangle of the neck and axilla [390]. Cystic hygroma is also known as “cystic lymphangi­oma” and “macrocystic lymphatic malformation” [391].
t.me/Dr_Mouayyad_AlbtousH
10 Lateral Cervical Swellings
247
10.7.1.2 Etiology
Embryologically, cystic hygromas originate from sequestration of lymphatic tissue from lymphatic sacs during the development of lymphatico­venous sacs [392]. It is because of this that they commonly occur in the posterior triangle of the neck [393]. These sequestered tissues fail to communicate with the remainder of the lym­phatic or venous system [394]. Later on, dilata­tion of the sequestered lymphatic tissues ensues, resulting in the cystic morphology of these lesions [395].
10.7.1.3 Epidemiology
Cystic hygromas are rare, accounting for approx­imately 6% of all benign lesions of infancy and early childhood [396]. They are, however, the most commonly presenting subtype of lymphan­gioma. Of all cystic hygromas, 75–90% is cervi­cal, 20% axillary, and the remainder is seen in other rare sites such as the inguinal region, retro­peritoneal space, and mediastinum [397].
10.7.1.4 Clinical Picture
History-Taking
Currently, cystic hygromas are increasingly diag­nosed by pre-natal US; a common sign is a neck growth. More than 60% of cystic hygromas have onset at birth and up to 90% become overt before the age of 2years [398402].
The usual presentation of cystic hygroma apparent at birth is a large, diffuse, painless mass with worries the parents. Its size varies from few cm to a huge lump lling the whole side of the neck, left more than right, causing respiratory distress and feeding difculty due to compression of major structures within the neck, such as the larynx, trachea, or esophagus [403]. The swelling is painless, non-tender, and slowly growing, but occasionally, as a result of infection, it increases rapidly in size, becomes painful and exquisitely tender, with erythematous overlying skin and the patient may become febrile [389, 399, 400]. Rarely, children with cystic hygromas display symp­toms of newly onset obstructive sleep apnea syndrome (OSAS) [404].
Physical Examination
Cystic hygroma appears soft/cystic, partially compressible (but nor reducible), non-tender, freely mobile, trans-illuminant, and non- pulsatile. It is dull to percussion and uctuates easily. Cystic hygroma develops in the SC tissues, thus, it is supercial to the neck muscles and close to the skin but are rarely xed to it. The overlying skin can take on a bluish hue or may appear nor­mal. A cyst in the posterior triangle may deeply extend beneath the SCM muscle into the retro­pharyngeal space. It may be unilateral or bilat­eral. Local LNs should not be enlarged [397].
Cystic hygromas have been found to be asso­ciated with certain conditions, such as nuchal lymphangioma, hydrops fetalis, and intra-uterine death [405, 406]. Additionally, they can be asso­ciated with chromosome abnormalities in 25–70% of affected children such as Down syn­drome, Turner syndrome, Klinefelter syndrome, trisomy 18 and trisomy 13, though these are not considered to be causative [407].
Complications that may be encountered with cystic hygroma include difcult labor, infection [408], bleeding [409], compression (respiratory distress, dysphagia), sinus formation (due to infection or trauma) [398400], and deformity (deformation of surrounding bony cranio-facial structures or dentition, if left untreated).
10.7.1.5 Evaluation/Diagnosis
Antenatal Evaluation
On antenatal US, the characteristic appearance is a multi-septate, thin-walled cystic mass that may have a more complex echo texture with cystic and solid components [410]. Detection of a cystic malformation may prompt further investigation, such as amniocentesis, to evaluate for genetic abnormalities in the fetus, which may be found in about 62% of cases [394].
Poste-natal Evaluation
Imaging Studies
Different imaging modalities such as MRI, CT scan, and US are all helpful in delineating the nature of a cystic neck mass [411]. Sonography
t.me/Dr_Mouayyad_AlbtousH
248
M. Sakr
of the lesion usually demonstrates a multicystic lesion with internal septations and no blood ow on color Doppler US [395]. Usually, CT scan and MRI can be employed to help in ascertaining the extent of the lesion and its relation to nerves and vessels and are particularly useful when surgical management of the lesion is contemplated [395,
412]. Both, CT and MRI reveal a ring-like mar-
gin enhancement with sharp demarcation of cys­tic areas. The imaging study of choice is MRI.It provides the best soft-tissue detail and can delin­eate the relation of the lesion to surrounding structures. Contrast can be used to differentiate hemangiomas from lymphangiomas. On MRI, cystic hygromas appear hyper-intense on T2-weighted images and hypo-intense on T1-weighted images.
Pathology/Histological Findings
Histologically, cystic hygromas are characterized by the proliferation of small lymphatic vessels combined with brous tissue [413]. They exhibit large macroscopic cystic spaces that are usually multilocular, but may be unilocular in about 10% of cases [397]. These spaces are lined by a single­layer endothelium with a connective-tissue stroma, and lled with clear- to straw-colored uid, which is eosinophilic and protein-rich [414]. Deep locules are quite large in size, but they decrease in size toward the surface [403]. Individual cysts may be isolated or may freely communicate. The surrounding stroma is brous or fatty and may contain lymphoid aggregates, smooth muscle, or other local tissues.
Cystic hygroma is a benign disorder; it grows slowly, usually supercially, but may grow in any plane of the neck. They may grow rapidly due to the accumulation of lymph itself, blood second­ary to hemorrhage, or pus secondary to infection [415, 416].
10.7.1.6 Dierential Diagnosis
Congenital differentials include thyroglossal cysts, branchial cleft cysts, dermoid cysts, or ter­atomas and other germ cell tumors. Other differ­entials include goiter and ranula in addition to infective causes, such as reactive lymphadenopa­thies and neck abscess, or neoplastic causes, such
as lymphoma and soft-tissue tumors (rhabdo­myosarcoma, lipoma, etc). The clinician should also consider inammatory causes such as sar­coidosis, traumatic lesions such as hematomas, and vascular causes such as carotid body tumors.
10.7.1.7 Treatment
The most preferred modality of treating cystic hygroma remains complete surgical excision; however, many recent reports have increasingly documented remarkable results of treatment with sclerosant agents [398400, 408, 409, 416418]. Other treatment modalities that have been employed with variable results include simple drainage, aspirations, radiation, laser excision, radio-frequency ablation, and cauterization [416,
418, 419]. Treatment options will be individual-
ized depending on the size, anatomical location, and complications of the lesion.
The indications of treatment are recurrent bouts of infection in the lesion, respiratory dis­tress, dysphagia, hemorrhage inside cystic hygroma, sudden increase in the size of lesion, lymph discharging sinus, and disgurement [395]. The respiratory distress can be of severe nature necessitating a tracheostomy due to com­plete or signicant laryngeal or tracheal com­pressions by external and sometimes laryngeal lymphangiomas [400, 409, 416418, 420423].
10.7.1.8 Prognosis
In some series, the reported mortality has been as high as 2–6%, usually secondary to pneumonia, bronchiectasis, and airway compromise. Obviously, this gure is pertinent in the larger lesions. Prognosis (morbidity) of a patient with a cystic hygroma largely depends on the anatomi­cal site and whether or not the patient develops any secondary complications. In general, mor­bidity is related to cosmetic disgurement and impingement on critical cervical structures, such as nerves, vessels, and laryngo-tracheal complex.
Surgical excision of cystic hygroma generally has good outcomes with complete resolution and no recurrence provided the mass is completely excised; however, in some cases, the surgical excision complication rate can be as high as 53%
t.me/Dr_Mouayyad_AlbtousH
ticulum
Cr
10 Lateral Cervical Swellings
249
and recurrence rate up to 15–20% if residual tis­sue is left behind [392] This can be improved through the use of adjuncts, such as sclerosing agents. Cystic hygromas that are left without any intervention are likely to continue to enlarge and cause further complications. Unlike hemangio­mas, cystic hygromas do not commonly resolve spontaneously.
10.7.2 Pharyngeal Pouch (Zenker’s Diverticulum)
10.7.2.1 Denition/Synonyms
Zenker’s diverticulum (ZD) is an acquired, poste­rior, pulsion, pharyngeal outpouching (diverticu­lum) that develops in the hypopharynx, typically between the crico-pharyngeus (CP) muscle and the inferior pharyngeal constrictor muscle [424]. It is a “false” diverticulum as it only involves the mucosa and submucosal layers and does not involve the muscular layer.
Synonyms include posterior pharyngeal pul­sion diverticulum, pharyngo-esophageal pouch or diverticulum, retro-pharyngeal pouch or diver­ticulum, posterior pharyngeal pouch or diverticu­lum, crico-pharyngeal achalasia, and hypopharyngeal diverticulum.
resulting in herniation of the pharyngeal mucosa through the weak part at the junction between the inferior constrictor and CP muscle. The most popular pathogenetic theories are structural abnormalities of the CP muscle [430], increased hypopharyngeal pressure, increased crico­pharyngeal tone, and gastro-esophageal reux [431]. It is suggested that a ZD involves impaired CP muscle compliance, usually due to brotic changes causing increase in the hypopharyngeal pressure, leading to mucosal herniation at the weak point just above the CP [430, 432]. The resulting false diverticulum thus develops between the transverse bers of the CP muscle and the oblique bers of the inferior constrictor muscle (Fig.10.27) [430, 432]; this area is often known as “Killian triangle.”
10.7.2.4 Histopathology
Microscopic evaluation of the pouch usually shows a sac lined with stratied squamous epi­thelium, and the submucosa lining often shows brous tissue. No muscular layer exists (pseudo­diverticulum). Rarely, ulcerations or evidence of cancer, mainly SCC or carcinoma in situ, may be present. Fibrosis surrounding the diverticulum is common. Fibrous tissue limits the spread of material that extravasates from the diverticulum
10.7.2.2 Epidemiology
Although ZD is a rare disorder in the general population [425], yet it is the most common type of pharyngo-esophageal diverticulum [426]. Its incidence is estimated to be 1–2 per 100,000 patients/year and twice as common in males [427]. It is primarily seen in elderly individuals, peaking between the seventh and ninth decades of life [428]. The rate varies in different parts of the world being more common in Northern Europe, USA, and Canada; it rarely occurs in Japan and Indonesia and is extremely rare in Africans and Asians [429].
10.7.2.3 Etiology/Pathophysiology
Zenker’s diverticulum is believed to be a “pul­sion” diverticulum due to uncoordinated swal­lowing where the lower sphincter-like bers of the inferior constrictor muscle do not relax,
t.me/Dr_Mouayyad_AlbtousH
Inferior constrictor muscle
icopharyngeus
muscle
Zenker’s diver
Fig. 10.27 Anatomical site of Zenker’s diverticulum bulging between the inferior constrictor and crico­pharyngeus muscles
250
M. Sakr
during endoscopy thus reducing the likelihood of local abscess formation.
10.7.2.5 Clinical Presentation
Symptoms
This false diverticulum retains food particles and salivary secretions leading to regurgitation of food (with no acid or bile taste in it), halitosis, and dysphagia [433, 434]. Choking and bouts of cough may be present, and if aspiration of food particles occurs during night, a lung abscess may develop. As the pouch increases in size, it hangs down beside the esophagus causing dysphagia and/or a neck swelling. Dysphagia, which occurs in approximately 98% of patients, may be severe enough and long-standing (for months or years) to induce malnourishment and weight loss [434,
435].
Physical Examination oftheCervical Swelling
The swelling appears behind the SCM muscle at the junction of its upper and middle third, usually to the left. It increases in size after eating and straining and disappears on pressure with a gur­gle (Boyce sign). Its shape is indistinct because only part of its surface is palpable. The swelling can be compressed and sometimes emptied but not completely reduced. Its surface is smooth and consistency is soft and sometimes indentable. It is dull to percussion. It does not uctuate or trans-illuminate. Cervical LNs should not be enlarged.
A serious complication of ZD is aspiration leading to pneumonia, bronchiectasis, or lung abscess. Other complications include bleeding, ulceration, tracheal compression, stula formation with the trachea (diverticulo-tracheal stula), and obstruction of the esophagus. Since this disease is mainly a disease of the elderly, long-standing con­dition may lead to deterioration of pulmonary function, in addition to cachexia, dehydration, and malnutrition (from fear of eating). In these elderly patients with ZD, the prognosis is typically poor, and recurrence rate is high [436].
10.7.2.7 Investigations
Barium swallow with contrast video-uoroscopy provide information regarding the size, location, and characteristics of the mucosal lining of ZD, and can achieve diagnosis of the condition (Fig.10.28). Irregular or lling-defect within the diverticulum may denote solid food remnants or the presence of a carcinoma. Contrast video­uoroscopy is able to see the pouch from differ­ent angles and provide constant monitoring of swallowing, assessment of the function of pha­ryngeal muscles, and presence of absence of gas­tric reux [437].
10.7.2.6 Complications
Complications of ZD depend on the surgical approach taken, patient age and co-morbidities. Development of a SCC in the pouch is the most dangerous complication. It occurs in 0.5% of patients, with a male to female ratio of 5:1. It usu­ally affects long-standing diverticula of more than 7-year-duration. The patient as well as the clinician should be alert whenever there is increased dysphagia, weight loss, or blood in the regurgitated food. Most patients will require total pharyngo-laryngetomy (as for a post-cricoid car­cinoma) [436].
t.me/Dr_Mouayyad_AlbtousH
Fig. 10.28 Barium swallow showing the pharyngeal diverticulum (Zenker’s diverticulum) (red arrow)
10 Lateral Cervical Swellings
251
Esophagoscopy is essential for surgical evalu­ation. Staging of ZD is imperative to the overall evaluation. Endoscopy may reveal brosis around the diverticulum, which limits the risk of local abscess formation. It may also show pooling of food in the diverticulum.
10.7.2.8 Staging
There are three staging systems for ZD: Lahey, Morton, and Van Overbeek staging systems. Only one of the three may be used. Staging relies typi­cally on the size of the pouch; the bigger the size, the higher the staging [437]. Barium swallow with video-uoroscopy is the radiographic meth­ods used for staging.
Lahey classication includes the following:
– Stage I: Small mucosal protrusion is visible – Stage II: A denite sac is seen but the esopha-
gus and hypopharynx are in line
– Stage II: The hypopharynx is seen in line with
the diverticulum, and the esophagus is pushed
anteriorly and appears indented.
10.7.2.9 Dierential Diagnosis
Although rare, cancers, such as SCC may be present in conjunction with a ZD.This is impera­tive to rule out during an assessment. One must ask about smoking history and consumption of very hot or very cold liquids. Other differentials include achalasia, gastro-esophageal reux dis­ease (GERD) or Barrett’s esophagus, esophagitis, stroke in the acute setting, and ulcerations due to retention of food.
10.7.2.10 Treatment
Only symptomatic lesions need treatment; lesions <2cm rarely require any intervention. In some cases of ZD associated with achalasia, “Botulinum toxin” may help relieve symptoms of dysphagia. For all other large ZD, surgery is indi­cated; it is the mainstay treatment for symptom­atic ZD [438, 439]. Patient selection is essential; it is important to individualize optimal therapy for each patient.
Treatment options include open (transcervi­cal) and endoscopic (trans-oral) procedures. Open procedures include (1) diverticulectomy
[440], (2) diverticulopexy [441], (3) diverticular inversion (all three procedures are performed with or without crico-pharyngeal myotomy), and (4) crico-pharyngeal myotomy alone. Endoscopic procedures include (1) endoscopic diathermy application (Dohlman’s procedure), (2) endo- scopic laser treatment, and (3) endoscopic staple- assisted esophago-diverticulostomy. The decision whether to perform the laser-assisted, stapler- assisted, or open approach at the individ­ual patient level can be inuenced by many fac­tors, including age, co-morbidities [442], surgeon experience [443], size of the pouch [444], and patient anatomy.
Both open and endoscopic approaches can be accomplished with many techniques, each of which has its own advantages and disadvantages [436]. Based on current evidence, traditional “open surgery” is suitable for all kinds of diver­ticula, providing satisfactory long-term outcomes and acceptable complication rates. However, it needs general anesthesia and more invasive pro­cedures. “Rigid endoscopic treatment” can be done under general anesthesia and hyperexten­sion of the neck. It might be technically difcult where the diverticular septum cannot be well exposed. “Flexible endoscopic therapy” can be conducted without general anesthesia or neck hyperextension; however, it is only suitable for selected patients [445]. Each treatment option has its pros and cons, but it is important to per­form individualized therapy for each patient. Minimally invasive endoscopic therapy should be considered for debilitated patents with a middle­size diverticulum, and open surgery would be preferred when difculty of diverticulum expo­sure is predicted [446449].
10.7.3 Pneumatocele
10.7.3.1 Denition
Pulmonary pneumatoceles are thin-walled, air- filled cysts that develop within the lung parenchyma, usually in patients with emphy­sema and as a sequela to acute pneumonia, commonly caused by Staphylococcus aureus [441, 450, 451].
t.me/Dr_Mouayyad_AlbtousH
252
M. Sakr
10.7.3.2 Epidemiology
The incidence of postinfectious pneumatocele formation ranges from 2 to 8% of all cases of pneumonia in children [452]. However, the fre­quency can reach 85% in patients with Staphylococcal pneumonia. No specic racial or gender predilection is observed. Pneumatoceles are found more frequently in infants and young children. Kunyoshi et al. (2006) reported that 70% of pneumatoceles occurred in children younger than 3years [453].
10.7.3.3 Etiology
Infectious Causes
Infectious etiologies associated with pneumato­cele formation include the following (1) bacterial infections such as S. aureus (the most common),
Staphylococcal pneumoniae, Streptococcus pneumoniae, Hemophilus inuenza, Eschercia coli, group A Streptococci, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aerugi­nosa, and Mycobacterium tuberculosis, and (2)
viral infections (adenovirus).
Noninfectious Causes
Noninfectious etiologies include hydrocarbon ingestion, trauma, and positive pressure ventila­tion (especially among premature infants with respiratory distress syndrome) [441, 450, 451].
Hyper-Immunoglobulin E (IgE) Syndrome
Although no particular genetic predisposition is recognized, pneumatocele formation is associ­ated with hyper-immunoglobulin E syndrome (Buckley–Job syndrome) due to higher incidence of S. pneumonia resulting from immunode­ciency [454, 455].
10.7.3.4 Pathophysiology
The exact mechanism of pneumatocele formation remains controversial. An endo-bronchial ball­valve mechanism leading to distal dilatation of the bronchi and alveoli was proposed by Conway (1951) [456] and Carrey (1953) [457]. However, in 1972, Boisset concluded that pneumatoceles are caused by bronchial inammation that rup­tures the bronchiolar walls and causes the forma-
tion of “air corridors” [458]. Air dissects down these corridors to the pleura and forms pneuma­toceles, a form of sub-pleural emphysema [458].
Traumatic pneumatocele has a different patho­physiology from the infectious type [459], devel­oping in a two-step process. Initially, the lung is compressed by the external traumatic force, followed by rapid decompression from increased negative intra-thoracic pressure. A “bursting lesion” of the lung occurs and leads to pneumato­cele formation.
10.7.3.5 Clinical Presentation
History-Taking/Symptoms
Children present with typical features of pneu­monia, including cough, fever, and respiratory distress. No history ndings differentiate pneu­monia with or without pneumatocele formation.
Physical Examination
Clinical examination may reveal variable degrees (mild, moderate, or severe) of respiratory distress, with tachypnea, retractions, grunting, and nasal aring. High fever (40–41°C) is almost always present. Auscultation of the chest reveals focal or bilateral decreased breath sounds. Inspiratory crackles are frequently audible [441, 450, 451].
As the pneumonia resolves and the pneumato­cele persists, lung examination ndings can be normal or reveals focal decreases in breath sounds, depending on the size of the pneumato­cele. In most children admitted to the hospital, the average time from admission to the develop­ment of the pneumatocele is 4–7 days. Occasionally, pneumatoceles are present on the initial radiograph. A pneumatocele may appear as a cystic swelling at the root of the neck; it increases in size with straining and cough and decreases with compression [441, 450, 451].
10.7.3.6 Complications
A tension pneumatocele can develop if air­trapping continues, most frequently with PPV [460]. Expansion of the pneumatocele can cause hemodynamic instability and severe airway obstruction. If untreated, this can result in respi­ratory failure and death.
t.me/Dr_Mouayyad_AlbtousH
10 Lateral Cervical Swellings
253
Pneumothorax can occur from a pneumato­cele rupturing into the pleural space causing lung collapse or broncho-pleural stula. Pyopneumothorax, hemo-thorax, hemopneumo­thorax, and pneumo-mediastinum have also been
contrast is not necessary to diagnose a pneumato­cele but occasionally helps to differentiate it from a lung abscess. Rarely, CT-guided needle aspira­tion of the pneumatocele can relieve compression from a large and/or tension pneumatocele.
reported in the literature [461].
Secondary infection may occur, requiring drainage to prevent the development of severe lung abscess that may require surgical excision. Drainage can be both diagnostic and therapeutic. If drained, the uid should be cultured for bacte­ria and fungus [462].
10.7.3.7 Investigations
Procedures
Percutaneous catheter drainage is done in the presence of a signicant tension pneumatocele, or a secondarily infected pneumatocele, to improve the patient’s cardiovascular status [463,
464].
Histological Features
Pathology is not commonly observed because
Laboratory Studies
If ndings are positive, blood culture can guide antibiotic therapy. Sputum analysis is a good noninvasive method to discover potential patho­gens. Culturing pleural uid from thoracentesis can also identify the causative organism. Tests for bacterial antigen detection can be performed on blood, urine, and pleural uid.
most pneumatoceles resolve without surgical resection. However, a few reports documented necrotic material around the pneumatocele. Cavity walls can contain organized inammatory cells with focal collections of multinucleated giant cells. In 1972, Boisset reported the pres­ence of “air corridors” between the bronchiolar lumen and the interstitial space [361].
Imaging Studies
Pneumatoceles are usually evident on chest radiographs by days 5–7 of hospitalization. Rarely, it may be visible on the initial chest radio­graph. Initial chest X-ray may reveal pneumonia, pneumatocele (Fig.10.29), para-pneumonic effu­sion or empyema. Usually, chest CT scan with
Fig. 10.29 Plain X-ray chest showing pneumonia with multiple pneumatoceles
10.7.3.8 Dierential Diagnosis
A pneumatocele should be differentiated from a cystic or compressible mass in the lateral side of the neck. Differentials also include bronchogenic
cyst, cystic adenomatoid malformation, pneumo­coccal infections, pneumonia, pulmonary seques- tration, S. aureus infection, and Tuberculosis
(TB).
10.7.3.9 Treatment
Accurate and early diagnosis is the key to a suc­cessful treatment of patients with pneumatocele. Treatment of the underlying pneumonia with antibiotics is the rst-line therapy. Close observa­tion in the early stages of the infection and peri­odic follow-up care until resolution of the pneumatocele is usually adequate treatment [465]. In most circumstances, pneumatoceles are asymptomatic and do not require surgical inter­vention. Conservative treatment includes the use of high-frequency oscillation ventilation (HFOV), decreasing the mean airway pressure, positioning affected side down, and unilateral ventilation of unaffected lung [441, 466468].
t.me/Dr_Mouayyad_AlbtousH
254
M. Sakr
Percutaneous needle decompression is consid­ered when the pneumatocele has the following characteristics: (1) occupying greater than 50% of the hemi-thorax [29], (2) creating signicant atelectasis, (3) broncho-pleural stulae develop­ment, (4) tension pneumatocele [469], (5) persis­tent signs of chest infection or infection within the cyst, and (6) the risk of inability to follow-up the patient in the outpatient clinic. Kogutt etal. (1999) reported that percutaneous needle decom­pression of a pneumatocele may carry the risk of the development of broncho-pleural stula [470].
Percutaneous catheter drainage of a pneuma­tocele that involves more than 50% of the hemi­thorax with severe atelectasis, tension pneumatocele, broncho-pleural stula, or infected pneumatocele is rarely needed. The pneumatocele can also be successfully managed by the injection of brin sealant via a pigtail cath­eter [464]. Recently, Muniraman et al. (2021) reported that bedside US-guided chest tube drain­age was successfully used to decompress a large pneumatocele in an unstable preterm infant [471].
Surgical resection is almost never required for the management of pneumatoceles. The indica­tions for video-assisted thoracoscopic surgery or open surgery include (1) prolonged, persistent air leak, (2) hemo-thorax or pneumo-thorax due to pneumatocele rupture, (3) failure of lung expan­sion, (4) progressive enlargement of the pneuma­tocele, and (5) compression of functional parenchyma. Video-assisted thoracoscopy has recently been used successfully to treat enlarging multicystic cases [467].
10.7.3.10 Prognosis
In general, a noncomplicated pneumatocele car­ries an excellent prognosis. The natural course is slow, but complete resolution with no further clinical sequelae usually occurs within 3months to 2years. However, rare complications, includ­ing tension pneumatocele, can lead to death from respiratory or cardiovascular collapse due to pro­gressive enlargement of the pneumatocele. Thus, if complications happen, early surgical interven­tion would be benecial to avoid mortality/mor­bidity [472].
References
1. Hiatt JL. Textbook of head and neck anatomy. Philadelphia, PA: Lippincott Williams and Wilkins;
2001.
2. Standring S.Gray’s anatomy: the anatomical basis of clinical practice. 41st ed. London, UK: Elsevier Health Sciences; 2015.
3. Gor DM, Langer JE, Loevner LA.Imaging of cervi­cal lymph in head & neck cancer: the basics. Radiol Clin North Am. 2006;44:101–10.
4. La Muraglia GM, Patel VI. Carotid artery: carotid body tumors and other disorders. In: Cronenwett J, Johnston KW, editors. Rutherford’s vascular surgery. 7th ed. Saunders Elsevier: London; 2010. p.1598–605.
5. Sciacovelli M, Schmidt C, Maher ER, Frezza C.Metabolic drivers in hereditary cancer syndromes. Ann Rev Cancer Biol. 2020;4:77–97.
6. Subha ST, Raman R, Prepageran N. Glomus tym­panicum: a report of two cases. Med J Malyasia. 2005;60(1):106–8.
7. O’Neill S, O’Donnell M, Harkin D, Loughrey M, Lee B, Blair P. A 22-year northern Irish Expe­rience of carotid body Tumours. Ulster Med J. 2011;80:133–40.
8. Taha AY.Carotid body tumours: a review. Int J Clin Med. 2015;6(3):119–31.
9. Sajid MS, Hamilton G, Baker DM;. A multicenter review of carotid body tumour management. Eur J Vasc Endovasc Surg. 2007;34:127–30.
10. Knight TT Jr, Gonzalez JA, Rary JM, Rush DS.Current concepts for the surgical management of carotid body tumor. Am J Surg. 2006;191(1):104–10.
11. Sevilla Garcia MA, Llorente Pendas JL, Rodrigo Tapia JP, Garcia Rostan G, Suarez Fente V, Coca PA. Head and neck paragangliomas: revision of 89 cases in 73 patients. Acta Otorrinolaringol Esp. 2007;58(3):94–100.
12. Tayyab M, Khan MR, Sophie Z. Presentation and management of carotid body tumors. IPMA. 2003;53(7):1–5.
13. Williams MD.Paragangliomas of the head and neck: an overview from diagnosis to genetics. Head Neck Pathol. 2017;11(3):278–87.
14. Netterville JL, Reilly KM, Robertson D, Reiber ME, Armstrong WB, Childs P. Carotid body tumors: a review of 30 patients with 46 tumors. Laryngoscope. 1995;105:114–26.
15. Karatas E, Sirikci A, Baglam T, Mumbuc S, Durucu C, Tutar E.Synchronous bilateral carotid body tumor and vagal paraganglioma: a case report and review of literature. Auris Nasus Larynx. 2008;351:171–5.
16. Gardner P, Dalsing M, Weisberger E, Sawchuk A, Miyamoto R.Carotid body tumors, inheritance, and a high incidence of associated cervical paraganglio­mas. Am J Surg. 1996;172(2):196–9.
17. Albert (1889). Cited in: Staats EF, Brown RL, Smith RR.Laryngoscope. 1966;76:907.
t.me/Dr_Mouayyad_AlbtousH
10 Lateral Cervical Swellings
255
18. Wieneke JA, Smith A.Paraganglioma: carotid body tumor. Head Neck Pathol. 2009;3:303–6.
19. Shibuya Y, Umeda M, Yoshikawa T, Komori T. Carotid body tumour. Oral Oncol. 2002;38(3):313–7.
20. Gupta B, Mitra JK. Anaesthetic management of chemodectoma excision. Indian Anesthet Forum. 2014;8(4):1–7.
21. Favier J, Gimenez-Roqueplo AP. Pheochromocytomas: the (pseudo)-hypoxia hypothesis. Best Pract Res Clin Endocrinol Metab. 2010;24(6):957–68.
22. Boedeker CC.Paragangliomas and paraganglioma syndromes. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc03. https://doi.org/10.3205/
cto000076.
23. Patetsios P, Gable DR, Garrett WV, Lamont JP, Kuhn JA, Shutze WP, etal. Management of Carotid Body Paragangliomas and Review of a 30-year experi­ence. Ann Vasc Surg. 2002;16:331–8.
24. Emad E, Shekoufeh Y, Arunthevaraja K, Isabel M, Ozhan T, etal. Paraganglioma presenting as hypoxia and syncope in pregnancy: a case report. A&A Practice. 2021;15:e01411.
25. Rosa M, Sahoo S. Bilateral carotid body tumor: the role of ne-needle aspiration biopsy in the preoperative diagnosis. Diagn Cytopathol. 2008;36(3):178–80.
26. Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg. 1971;122(6):732–9.
27. Makeieff M, Raingeard I, Alric P, Bonafe A, Guerrier B, Marty-Ane C. Surgical manage­ment of carotid body tumors. Ann Surg Oncol. 2008;15(8):2180–6.
28. Ferreira J, Canedo A, Braga S, Vasconcelos J, Gouveia R, Martins V, Brandão P, Vaz A. Carotid body tumours resection with ultrasound dissector. Chinese Med J. 2013;126:586–8.
29. Sahin MA, Jahollari A, Guler A, Doganci S, Bingol H, Karaman B, etal. Results of combined preopera­tive direct percutaneous embolization and surgical excision in treatment of carotid body tumors. Vasa. 2011;40(6):461–6.
30. Cobb AN, Barkat A, Daungjaiboon W, Halandras P, Crisostomo P, Kuo PC, etal. Carotid body tumor resection: just as safe without preoperative emboli­zation. Ann Vasc Surg. 2018;46:54–9.
31. Biswas D, Marnane CN, Mal R, Baldwin D. Extracranial head and neck schwannomas-a 10-year review. Auris Nasus Larynx. 2007;34:353–9.
32. van der Mey AG, Jansen JC, van Baalen JM. Management of carotid body tumors. Otolaryngol Clin N Am. 2001;34(5):907–24.
33. Kim GY, Lawrence PF, Moridzadeh RS, Zimmerman K, Munoz A, Luna-Ortiz K, etal. New predictors of complications in carotid body tumor resection. J Vasc Surg. 2017;65(6):1673–9.
34. Carlsen CS, Godballe C, Krogdahl AS, Edal AL.Malignant vagal paraganglioma: report of a case treated with embolization and surgery. Auris Nasus Larynx. 2003;30(4):443–6.
35. Darouassi Y, Alaoui M, Mliha Touati M, Al Maghraoui O, En-Nouali A, Bouaity B, etal. Carotid body tumors: a case series and review of the litera­ture. Ann Vasc Surg. 2017;43:265–71.
36. Watkinson JC, Gaze MN, Wilson JA. Metastatic neck disease. In: Watkinson JC, Gaze MN, Wilson JA, editors. Stell & Maran’s head & neck surgery. 4th ed. Oxford, Auckland, Boston, Johannesburg, Melbourne, New Delhi: Butterworth Heinemann;
2000. p.201–32.
37. Blair RL. Head & neck surgery. In: Cuschieri A, Steele RC, Moosa AR, editors. Essential surgical practice. 4th ed. 2002. p.1045.
38. Sampath CP, Nikhil T, Pallavi K, Chandra P. Paragangliomas of the head & neck: the KMC experience. Indian J Otolaryngol Head Neck Surg. 2011;63(1):62–73.
39. Maran AGD. Benign diseases of the neck. Scott Brown’s Otolaryngol. 1987;5:283–300.
40. Batsakis JG.Tumours of the peripheral nervous sys­tem. Baltimore, MD: Williams and Wilkins; 1979. p.313–33.
41. Chiofalo MG, Longo F, Marone U, Franco R, Petrillo A, Pezzullo L.Cervical vagal schwannoma. A case report. Acta Otorhinolaryngol Ital. 2009;29:33–5.
42. Kim SH, Kim NH, Kim KR, Lee JH, Choi HS. Schwannoma in head and neck: preopera­tive imaging study and intracapsular enucleation for functional nerve preservation. Yonsei Med J. 2010;51:938–42.
43. Kang GC, Soo KC, Lim DT. Extracranial non­vestibular head and neck schwannomas: a ten-year experience. Ann Acad Med Singap. 2007;36:233–8.
44. Balle VH, Greissen O.Neurilemmoma of the facial nerve presenting as parotid tumour. Ann Otol Rhinol Laryngol. 1984;93:70–2.
45. Mohammad A, Iqbal MA, Wadhwania A.Schannoma of the ehad and neck region: a report of two cases with a narrative review of literature. Cancer Res Stat Treat. 2020;3:517–3.
46. Batsakis JG, Sneige N.Parapharyngeal and retropha­ryngeal space diseases. Ann Otol Rhinol Laryngol. 1989;98:320–1.
47. Diaz DD, Kennedy KS, Parker GS, White VJ.Schwannoma of the submandibular gland. Head Neck. 1991;13:239–42.
48. Dhupar V, Yadav S, Dhupar A, Akkara F.Cavernous hemangioma-uncommon presentation in zygomatic bone. J Craniofac Surg. 2012;23:607–9.
49. Leu YS, Chang KC. Extracranial head and neck schwannoma-a review of 8 years experience. Acta Otolaryngol. 2002;122:435–7.
50. Muranjan SN, Jagasia V, Pusalkar A. Schwannoma of the cheek. Indian J Otolaryngol Head Neck Surg. 2001;53:140–1.
t.me/Dr_Mouayyad_AlbtousH